A D V A N C E C O P Y -N O T F I N A L V E R S I O N
T he availabilit y of organ transplantation-the only treatment for end-stage organ failure-is severely limited by the shortage of donor organs. The critical, unmet need for alternative treatments has spurred development of tissue engineering and regenerative medicine approaches to generate replacement organs. Whole-organ decellularization has been developed to produce three-dimensional tissue scaf folds with native extracellular matrix (ECM) and preserved microvasculature (1) . Here, we introduce a new approach to generate a native decellularized ECM scaffold in situ, which serves to facilitate in vivo engraftment of exogenous cells into a solid organ. Our approach is based on the concept that an appropriate niche must first be created within a host organ in order for new cells to engraft efficiently. Non-thermal irreversible electroporation (NTIRE) is a tissue ablation technique that employs high electric field pulses microseconds in length to irreversibly permeabilize the cell membrane, thereby causing cell death (2) . NTIRE treatment leaves behind an intact ECM in which new cells engraft, often without scar tissue formation (2) (3) (4) (5) (6) (7) . This unique feature of NTIRE suggests it could be used as a method for decellularizing organs (5, 8, 9) .
Inspired by the earlier work, we hypothesized that NTIRE could be utilized to remove host cells from tissues while leaving behind an intact ECM, creating a suppor tive niche in situ for the in vivo engraftment of exogenous cells. To test this hypothesis, we treated the livers of mice with NTIRE and subsequently i m p l a nte d exo g e n o u s c o n g e n i c hepatocytes within the treated volume.
A l l a n i m a l p ro c e d u r e s we r e performed in accordance to protocols approved by the Institutional Animal Care and Use Committee at UCSF. After induction of general anesthesia, the abdomen of a wild-type C57BL/6 mouse was aseptically prepared, and the liver was exposed by making a 1 cm midline incision below the xiphoid. Two needle electrodes, each 0.5 mm in diameter and spaced 4 mm apart, were connected to an ECM 830 Square Wave Electroporation System (BTX Har vard Apparatus, Holliston, MA) and inserted into the left lobe, perpendicular to the liver surface. Electrical pulses were applied using the following parameters: 500 V/cm (voltage over distance) and eight 100-µs pulses with each pulse separated by 100 ms. These parameters were chosen because they represent the threshold for inducing irreversible electroporation (10). Other studies have employed different electrodes that applied higher electric fields and many more pulses (4, 9) . We used the lower threshold because recent studies showed that the larger numbers of pulses induced electrolysis and might not produce pure irreversible electroporation (11) .
We found that the time course of tissue injury in response to NTIRE ablation in the mouse liver was comparable to that observed in pig and rat livers (3, 4) , blood vessels (5), and small intestines (12 
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METHOD SUMMARY
Mouse liver was treated with non-thermal irreversible electroporation (NTIRE) electrical pulses in vivo. A few days later, the treated tissue was then implanted with exogenous hepatocytes, which successfully engrafted into the liver tissue.
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af ter NTIRE treatment, there were no overt signs of cell death or tissue injury ( Figure 1) . By 24 hours, the liver parenchyma showed injured hepatocytes with a vacuolated, moth-eatenappearing cy toplasm. At 3 days, there was massive ballooning degeneration of hepatocy tes throughout the NTIRE-treated tissue. The pathogenesis of ballooning degeneration is not completely known, but there is evidence that it represents terminally injured cells that cannot complete the apoptotic program (13) . By 7 days, the NTIRE-injured tissue had repaired itself, and ballooned hepatocytes were no longer found. Importantly, there was no extensive infiltration of inflammatory cells, abnormal deposition of collagen, or scar formation after NTIRE treatment.
Time-course studies suggested that the optimal timing of in vivo exogenous hepatocyte implantation was 3 days after NTIRE treatment, a time point after host hepatocyte cell death had peaked. Therefore, we treated the livers of mice with NTIRE as described above and then introduced donor hepatocytes by direct parenchymal implantation 3 days later. Primary hepatocytes were isolated from B6.129S7-Gt(ROSA)26Sor/J (ROSA26) mice, in which b-galactosidase is constitutively expressed in all cells so that implanted hepatocytes could be easily identified by X-gal staining in wild-type C57BL/6 re c i p i e nts. R O S A 26 m i c e we re anesthetized, and primary hepatocyte isolation was performed by two-step per fusion (14) . One million freshly isolated hepatocytes were loaded into a PE50 catheter (BD Biosciences, San Jose, CA) connected to a glass syringe with a screw-drive (Hamilton, Reno, NV). C57BL/6 mice pre-treated with NTIRE were anesthetized, and the previously made midline incision was re-opened. A hepatotomy was made using a 25-gauge needle in the left hepatocytes (arrowheads) or clusters (arrows) had integrated with the host parenchyma near or along the implantation scar (asterisks). Although total cell numbers were not significantly increased, there were larger clusters of X-gal + hepatocytes in the livers of NTIRE-treated mice (n = 3) compared to controls (n = 3). For all mice, serial cryosections were obtained through the entire implanted liver lobe from the anterior surface to the posterior surface, and X-gal + cells were manually counted in all sections. Scale bar = 400 µm (5×) and 60 µm (40×).
liver lobe, in between the two needle electrode insertion sites. The catheter loaded with hepatocytes was inserted into the hepatotomy site, and donor hepatocytes were implanted by slowly turning the screw-drive of the syringe (15) . Recipient wild-type mice that did not receive NTIRE pre-treatment were used as controls. At 3 and 14 days post-implantation, serial cr yosections were obtained through the entire recipient liver lobe from the anterior to the posterior surfaces. Hepatocytes that stained positive for X-gal (blue) were manually counted in each section to determine the total number of engrafted hepatocytes in each recipient mouse. The hepatotomy performed at the time of implantation created a space within the liver parenchyma (Figure 2A , 5× magnification). The majority of implanted cells within this space eventually die by necrosis (15) . Exogenous cells that successfully engrafted were at the periphery of this space and had to migrate past the zone of inflammator y cells to incorporate within the host parenchyma (Figure 2A , 40× magnification). Livers from NTIREtreated mice showed significantly greater numbers of X-gal + hepatocytes within and beyond the inflammatory zone compared to livers from control mice that did not receive NTIRE pre-treatment (Figure 2A , bar graph). At 14 days after implantation, X-gal + donor hepatocytes appeared integrated with the host parenchyma near or along the scar left behind by the implantation tract ( Figure 2B , 5× magnification). Livers pretreated with NTIRE showed larger X-gal + cell clusters compared to controls ( Figure  2B , 40× magnification). These observations suggest that, with further optimization of electroporation protocols and surgical approach, improved donor cell engraftment may be achieved in NTIRE-treated liver tissue after direct exogenous cellular implantation in vivo.
We showed that exogenous hepatocytes engrafted into the niche prepared by NTIRE pre-treatment of the liver. Our study is the first to demonstrate the feasibility of this regenerative surgical approach that may be generalizable to other organs and cell types.
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